TWD 28.05
(-3.28%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 20.19 Million TWD | 27.36% |
2022 | 15.85 Million TWD | 128.52% |
2021 | 6.93 Million TWD | -47.97% |
2020 | 13.33 Million TWD | 2.85% |
2019 | 12.96 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 7.08 Million TWD | 61.79% |
2024 Q1 | 4.37 Million TWD | -29.15% |
2023 Q4 | 6.17 Million TWD | 6.79% |
2023 FY | 20.19 Million TWD | 27.36% |
2023 Q2 | 4.52 Million TWD | 22.22% |
2023 Q1 | 3.7 Million TWD | -27.29% |
2023 Q3 | 5.78 Million TWD | 27.81% |
2022 FY | 15.85 Million TWD | 128.52% |
2022 Q4 | 5.09 Million TWD | 0.0% |
2021 FY | 6.93 Million TWD | -47.97% |
2020 FY | 13.33 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Level Biotechnology Inc. | 660.61 Million TWD | 96.943% |
Sagittarius Life Science Corp | 440.46 Million TWD | 95.415% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 88.816% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 98.188% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | 68.799% |
TaiMed Biologics Inc. | 491.77 Million TWD | 95.893% |
GlycoNex Incorporation | 2.54 Million TWD | -694.493% |
VBI | 55.85 Million TWD | 63.841% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 91.042% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 93.609% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 94.902% |
Visgeneer Inc. | 147.99 Million TWD | 86.354% |
Mycenax Biotech Inc. | 652.62 Million TWD | 96.905% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 98.804% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 88.869% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
Neith Corporation | 39.9 Million TWD | 49.387% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 94.817% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 11.195% |
Enimmune corporation | 43.49 Million TWD | 53.566% |
TaiRx, Inc. | 5.08 Million TWD | -297.403% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 98.025% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 92.371% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 95.29% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 81.625% |
Lukas Biomedical Inc. | 231.83 Million TWD | 91.289% |
RBC Bioscience Corporation | 172.46 Million TWD | 88.29% |
BiOptic Inc. | 228.26 Million TWD | 91.153% |
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -2674.176% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -22340.0% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -112.054% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -316.412% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 98.901% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | -1571.854% |
Lin BioScience, Inc. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | 10.164% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 85.694% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -2408.82% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 97.477% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 64.516% |
AP Biosciences Inc | 32.25 Million TWD | 37.383% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 98.256% |
3D Global Biotech Inc. | 20.63 Million TWD | 2.118% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 93.578% |
Intech Biopharm Corporation | 25.84 Million TWD | 21.863% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | 76.728% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 97.337% |
TCI GENE Inc. | 333.85 Million TWD | 93.951% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -112100.0% |
Senhwa Biosciences, Inc. | 1 Million TWD | -1919.6% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 76.371% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 87.389% |
PharmaEngine, Inc. | 767.66 Million TWD | 97.369% |
Savior Lifetec Corporation | 1.05 Billion TWD | 98.077% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 83.598% |
OBI Pharma, Inc. | 41.54 Million TWD | 51.392% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 91.382% |
Acepodia, Inc. | 16.59 Million TWD | -21.714% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | 48.125% |